Published in Arch Med Sci on November 05, 2013
Reversible Cardiomyopathies. Clin Med Insights Cardiol (2015) 0.88
The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation. Arch Med Sci (2016) 0.81
QT Prolongation due to Graves' Disease. Case Rep Cardiol (2017) 0.75
Relationship between the abnormal diastolic vortex structure and impaired left ventricle filling in patients with hyperthyroidism. Medicine (Baltimore) (2017) 0.75
Autoantibodies of β-adrenergic and M2 cholinergic receptors: atrial fibrillation in hyperthyroidism. Endocrine (2015) 0.75
Thyroid Hormone Profile in Patients With Acute Coronary Syndrome. Iran Red Crescent Med J (2015) 0.75
Effect of non-genomic actions of thyroid hormones on the anaesthetic effect of propofol. Exp Ther Med (2015) 0.75
microRNA and thyroid hormone signaling in cardiac and skeletal muscle. Cell Biosci (2017) 0.75
Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literature. Pragmat Obs Res (2017) 0.75
Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet (2001) 7.92
Thyroid hormone and the cardiovascular system. N Engl J Med (2001) 5.56
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med (2012) 3.52
All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science (1986) 2.57
Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med (1995) 1.95
The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am (1997) 1.75
Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1994) 1.69
The thyroid and the heart. Circulation (1993) 1.67
Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res (2004) 1.67
Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. Endocrinology (1996) 1.66
Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. J Clin Endocrinol Metab (1997) 1.54
Influence of thyroid dysfunction on drug pharmacokinetics. Clin Pharmacokinet (1981) 1.49
Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci U S A (1992) 1.49
The management of atrial fibrillation. Am J Med (1996) 1.45
Management of atrial fibrillation in the post-thyrotoxic state. Am J Med (1982) 1.42
High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med (2008) 1.39
Regulation of myosin heavy chain genes in the heart. Circulation (1993) 1.37
Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med (1990) 1.37
Acute effects of thyroid hormone on vascular smooth muscle. Thyroid (1996) 1.35
Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J (2001) 1.33
Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol (2010) 1.28
Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Circ Res (1994) 1.27
Review: The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J Clin Endocrinol Metab (2007) 1.23
Stroke in thyrotoxicosis with atrial fibrillation. Stroke (1988) 1.17
Thyroid hormone regulates expression of a transfected human alpha-myosin heavy-chain fusion gene in fetal rat heart cells. Proc Natl Acad Sci U S A (1990) 1.14
Biochemical basis of thyroid hormone action in the heart. Am J Med (1990) 1.10
Thyrotoxic cardiac disease. Curr Heart Fail Rep (2008) 1.09
Unusual manifestations of hypothyroidism. Arch Intern Med (1984) 1.06
Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab (2000) 1.05
The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Res (2009) 1.03
The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg (1997) 1.03
Hyperthyroidism-induced left ventricular diastolic dysfunction: implication in hyperthyroidism-related heart failure. Clin Endocrinol (Oxf) (2011) 1.01
Increased myocardial beta-receptors and adrenergic responses in hyperthyroid pigs. Am J Physiol (1987) 1.00
Mechanisms for synergistic activation of thyroid hormone receptor and retinoid X receptor on different response elements. J Biol Chem (1994) 1.00
MECHANISM OF CERTAIN ABNORMALITIES OF THE CIRCULATION TO THE LIMBS IN THYROTOXICOSIS. J Clin Invest (1965) 1.00
The molecular biology of thyroid hormone action. Ann N Y Acad Sci (1995) 0.99
Hyperthyroid heart disease. Clin Cardiol (2000) 0.98
A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol (2011) 0.98
Hyperthyroidism and the management of atrial fibrillation. Thyroid (2002) 0.97
The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy. J Clin Endocrinol Metab (2010) 0.96
The direct effects of 3,5,3'-triiodo-L-thyronine (T3) on myocyte contractile processes. Insights into mechanisms of action. J Thorac Cardiovasc Surg (1995) 0.95
Cardiovascular hemodynamics and exercise tolerance in thyroid disease. Thyroid (2002) 0.95
Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am (1998) 0.95
Effects of drugs on the efficacy of radioiodine (|) therapy in hyperthyroid patients. Arch Med Sci (2010) 0.94
Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart. Environ Toxicol Pharmacol (2010) 0.93
Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects. J Appl Physiol (1967) 0.92
Amiodarone and thyroid dysfunction. South Med J (2010) 0.92
Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol (2001) 0.92
Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2005) 0.92
Thyroid hormone receptor alpha 1: a switch to cardiac cell "metamorphosis"? J Physiol Pharmacol (2008) 0.91
Effect of thyroid hormone on the abundance of Na,K-adenosine triphosphatase alpha-subunit messenger ribonucleic acid. Mol Endocrinol (1987) 0.91
Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. J Clin Endocrinol Metab (1991) 0.91
Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology (2000) 0.90
Power spectral analysis of heart rate in hyperthyroidism. J Clin Endocrinol Metab (1996) 0.89
Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes. Mol Cell Endocrinol (2010) 0.88
Up-regulation of type 2 iodothyronine deiodinase in dilated cardiomyopathy. Cardiovasc Res (2010) 0.88
Cardiac myosin heavy chain gene regulation by thyroid hormone involves altered histone modifications. Am J Physiol Heart Circ Physiol (2010) 0.87
Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. Circulation (1997) 0.87
Congestive heart failure and sudden death in a young woman with thyrotoxicosis. West J Med (1988) 0.87
Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Circ Res (1998) 0.85
Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific. Endocrinology (1999) 0.85
PLasma renin activity in syndromes of thyroid hormone excess and deficiency. Life Sci (1982) 0.85
Increase in incidence of hyperthyroidism predominantly occurs in young people after iodine fortification of salt in Denmark. J Clin Endocrinol Metab (2006) 0.85
Hyperthyroidism and the heart. Hellenic J Cardiol (2008) 0.85
QTc dispersion in hyperthyroidism and its association with pulmonary hypertension. Pacing Clin Electrophysiol (2009) 0.85
Differential regulation of slow-skeletal and cardiac troponin I mRNA during development and by thyroid hormone in rat heart. J Mol Cell Cardiol (1994) 0.84
Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel expression: implication for atrial fibrillation in hyperthyroidism. Basic Res Cardiol (2011) 0.84
Thyroidal enhancement of rat myocardial Na,K-ATPase: preferential expression of alpha 2 activity and mRNA abundance. J Membr Biol (1990) 0.83
Pulmonary arterial hypertension and thyroid disease. J Bras Pneumol (2009) 0.83
Changes in autonomic regulation and ventricular repolarization induced by subclinical hyperthyroidism. Biomed Pharmacother (2009) 0.83
Bursting of cardiac sodium channels after acute exposure to 3,5,3'-triiodo-L-thyronine. Circ Res (1993) 0.83
Thyroid hormone inhibits ERK phosphorylation in pressure overload-induced hypertrophied mouse hearts through a receptor-mediated mechanism. Am J Physiol Cell Physiol (2010) 0.82
Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol (1989) 0.82
Echocardiographic studies on the relationship between atrial fibrillation and atrial enlargement in patients with hyperthyroidism of Graves' disease. Cardiology (1989) 0.82
Invited commentary: Cardiovascular mortality in subclinical hyperthyroidism: an ongoing dilemma. Eur J Endocrinol (2010) 0.81
Pleiotropic effects of thyroid hormones: learning from hypothyroidism. J Thyroid Res (2011) 0.80
Thyroid hormone receptor modulates the expression of the rabbit cardiac sarco (endo) plasmic reticulum Ca(2+)-ATPase gene. J Biol Chem (1994) 0.80
Thyroid hormones suppress epsilon-PKC signalling, down-regulate connexin-43 and increase lethal arrhythmia susceptibility in non-diabetic and diabetic rat hearts. J Physiol Pharmacol (2008) 0.80
The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy. J Thorac Cardiovasc Surg (1994) 0.79
Acute cellular actions of thyroid hormone and myocardial function. Ann Thorac Surg (1993) 0.79
Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res Cardiol (2010) 0.79
Dronedarone: an overview. Ann Med (2011) 0.78
Impaired functional and hemodynamic response to graded exercise testing and its recovery in patients with subclinical hyperthyroidism. Arq Bras Endocrinol Metabol (2011) 0.77
Effect of thyroid hormone on the distribution and activity of Na, K-ATPase in ventricular myocardium. Arch Biochem Biophys (2008) 0.77
Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. Metabolism (2000) 0.77
Connexin40 messenger ribonucleic acid is positively regulated by thyroid hormone (TH) acting in cardiac atria via the TH receptor. Endocrinology (2008) 0.77
[Prevention and multimodal therapy of hyperthyroidism]. Internist (Berl) (2008) 0.76
Hyperthyroidism: a stepwise approach to management. J Fam Pract (2011) 0.76
Changing axis deviation and paroxysmal atrial flutter associated with subclinical hyperthyroidism. Int J Cardiol (2009) 0.76
Atrial fibrillation: a symptom treated as a disease? Hellenic J Cardiol (2006) 0.75
25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women. Arch Med Sci (2012) 1.09
Nutraceuticals for metabolic syndrome management: from laboratory to benchside. Curr Vasc Pharmacol (2014) 0.88
Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers. Endocr Pathol (2012) 0.79
Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin. Arch Med Res (2008) 0.77